🧪
hypothesis

Mutant-dependent amplification is context-dependent and strongest in microglia and macrophages

Hypothesis

Mutant-dependent amplification is context-dependent and strongest in microglia and macrophages

A credible refinement is that any true amplification is not universal across cell types, but emerges most strongly in professional phagocytes with high endogenous LRRK2 activity, chronic cargo load, and active endolysosomal remodeling.
🧬 LRRK2,RAB10🩺 neurodegeneration🎯 Composite 74%💱 $0.60▼18.9%proposed
EvidencePending (0%)📖 7 cit🗣 1 debates 7 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.85 (15%) Evidence 0.75 (15%) Novelty 0.58 (12%) Feasibility 0.84 (12%) Impact 0.79 (12%) Druggability 0.82 (10%) Safety 0.63 (8%) Competition 0.64 (6%) Data Avail. 0.74 (5%) Reproducible 0.73 (5%) KG Connect 0.50 (8%) 0.740 composite
🏆 ChallengeResolve: Microglia-Targeted LRRK2 Inhibition Outperforms Pan-Cellular LRRK2 Inhi$500K →
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite74%

🧪 Overview

A credible refinement is that any true amplification is not universal across cell types, but emerges most strongly in professional phagocytes with high endogenous LRRK2 activity, chronic cargo load, and active endolysosomal remodeling. This would reconcile modest blood-cell baseline effects with larger functional consequences in microglia/macrophages relevant to inflammatory and trafficking phenotypes.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["LRRK2 G2019S Mutation<br/>Kinase Hyperactivity"]
    B["RAB10 Activation<br/>GTP-bound State"]
    C["RAB10 Phosphorylation<br/>T73 on ExoCycling Machinery"]
    D["GLUT4 Translocation<br/>Endosomal Recycling Defect"]
    E["ER-to-Golgi Transport<br/>Vesicle Cargo Delay"]
    F["Synaptic Vesicle Pool<br/>Reduced Recycling Rate"]
    G["Neuronal Homeostasis<br/>Impaired Lysosomal Trafficking"]
    H["alpha-Synuclein Aggregation<br/>PD-Relevant Pathology"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    C --> G
    G --> H
    style A fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix7 supports2 contradicts
Supports
LRRK2-Rab10 signaling is particularly prominent in phagocytic cells and regulates macropinocytosis and signaling endosomes.
PMID:32853409
Supports
Lysosomal stress and fibrillar alpha-synuclein activate LRRK2-Rab10 signaling and extracellular release in macrophage-lineage cells and microglia.
PMID:38313055
Supports
Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes.
Neuron2024PMID:39059388medium
Supports
LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition.
Proc Natl Acad Sci U S A2023PMID:37487100medium
Supports
Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes.
Cell2021PMID:34555357medium
Supports
LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model.
Commun Biol2025PMID:40796643medium
Supports
Biomarker of Neuroinflammation in Parkinson's Disease.
Int J Mol Sci2022PMID:35456966medium
Contradicts
Stronger responses in phagocytes could reflect higher LRRK2 abundance or cargo flux rather than a mutation-specific amplification mechanism.
PMID:32853409
Contradicts
A microglia-dominant phenotype may not fully explain dopaminergic neuronal vulnerability or patient therapeutic response.
PMID:38313055
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — LRRK2

🧬 PDB 6VP6 Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for LRRK2,RAB10 from GTEx v10.

Frontal Cortex BA93.5 Cortex3.3median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for LRRK2,RAB10 →

No DepMap CRISPR Chronos data found for LRRK2,RAB10.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Falling
7d Momentum
▼ 1.5%
Volatility
Low
0.0061
Events (7d)
3
Price History
▼18.9%

💾 Resource Usage

LLM Tokens
18,998
$0.0570
Total Cost
$0.0570

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF LRRK2 G2019S primary microglia and CD14+ peripheral monocytes are treated with LRRK2 kinase inhibitor MLi-2 (100 nM) for 24 hours, THEN pT73 RAB10 phosphorylation will be suppressed by >50% in micrMicroglia will show significantly greater RAB10 phosphorylation suppression than monocytes following LRRK2 inhibition, confirming cell-type-specific amplificati— no observation —pending0.45
IF LRRK2 G2019S microglia are stimulated with aggregated α-synuclein (1 µg/mL) for 48 hours, THEN RAB10-GTP loading will increase >2-fold relative to vehicle control, while peritoneal macrophages fromMicroglia will demonstrate stronger RAB10 activation than peritoneal macrophages in response to neurodegeneration-relevant cargo load, confirming professional p— no observation —pending0.42
🔮 Falsifiable Predictions (2)
pendingconf 45%
IF LRRK2 G2019S primary microglia and CD14+ peripheral monocytes are treated with LRRK2 kinase inhibitor MLi-2 (100 nM) for 24 hours, THEN pT73 RAB10 phosphorylation will be suppressed by >50% in microglia but <25% in monocytes, measured by quantitative phospho-SILAC proteomics.
Predicted outcome: Microglia will show significantly greater RAB10 phosphorylation suppression than monocytes following LRRK2 inhibition, confirming cell-type-specific a
Falsification: If RAB10 pT73 suppression is equivalent (<10% difference) or greater in monocytes compared to microglia, context-dependent amplification is not supported.
pendingconf 42%
IF LRRK2 G2019S microglia are stimulated with aggregated α-synuclein (1 µg/mL) for 48 hours, THEN RAB10-GTP loading will increase >2-fold relative to vehicle control, while peritoneal macrophages from the same mice will show <1.5-fold increase.
Predicted outcome: Microglia will demonstrate stronger RAB10 activation than peritoneal macrophages in response to neurodegeneration-relevant cargo load, confirming prof
Falsification: If peritoneal macrophages show equal or greater RAB10-GTP induction (>1.8-fold) compared to microglia, the hypothesis that amplification is strongest in brain-resident microglia is disproven.
View on SciDEX ↗